Anti-gout drug may decrease risk for colorectal adenoma progression
Allopurinol, a relatively inexpensive anti-gout medication that has been on the market for more than 20 years, may have some activity against colorectal adenomas, according to data presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, held here Nov. 7-10, 2010. Specifically, the presence of a colorectal tumor tissue biomarker, Ki67, was markedly decreased in the preliminary results of a study of patients with colorectal polyps assigned to take allopurinol.
"Allopurinol has a well-known and good safety profile, and a cost of approximately one euro for one month of treatment," said Andrea De Censi, M.D., director, medical oncology unit, Galliera Hospital, Genoa, and advisor, division of cancer prevention and genetics, EIO, Milan, Italy.
"In the era of very expensive target-therapy in oncology, it is important to search for cheap agents that could be active in cancer prevention and thus have huge public health implications," he said.
In colorectal tumor tissue there are high levels of ROM, or reactive oxygen metabolites.
"These ROMs are thought to be important for development of tumor tissue and carcinogenesis. It is known today that ROMs activate crucial processes involved in cell growth, and in processes that inhibit programmed cell death, one of the main mechanisms involved in cancer control," De Censi said.
Therefore, researchers are testing the effect of ROM scavengers, such as allopurinol, to measure their effects on chemoprevention. According to De Censi, previous research from a large case-control study conducted in Israel showed that patients under chronic allopurinol use for gout had a lower risk for colorectal cancer than a matched control group not using allopurinol.
In the current study, De Censi and colleagues conducted a Phase I/II double-blind, placebo-controlled trial of patients with colorectal adenomatous polyps. Between 2006 and 2010, 73 patients were enrolled and assigned placebo or either a 100-mg or 300-mg dose of allopurinol for four to six weeks prior to removal of polyps.
They collected normal and adenomatous tissue samples and measured changes in the biomarker Ki67 in the normal tissue and the adenomatous tissue to measure the effect of allopurinol. At an interim analysis, conducted in November of 2008, only three mild adverse gastrointestinal events had occurred, confirming the high safety profile of allopurinol.
Tissue analysis in the first 13 patients indicated that levels of Ki67 in normal tissue had doubled in patients taking placebo, but had only increased by 5 percent in patients taking either dose of allopurinol.
In adenoma tissue, levels of Ki67 increased by 70 percent in patients taking placebo compared with only 6 percent in patients taking 100 mg allopurinol and 12 percent in patients taking 300 mg allopurinol.
"Our findings need to be confirmed on a larger number of subjects. However, if the positive trend noted on Ki67 is confirmed, we will conclude that allopurinol has some activity against colon carcinogenesis that may explain the favorable trend noted in the epidemiological studies. These results will provide the background for a large trial of adenoma recurrence reduction with allopurinol," De Censi said.
Source: American Association for Cancer Research
Articles on the same topic
- New risk factor for developing breast cancerWed, 10 Nov 2010, 14:38:42 UTC
- Long-term statin use is unlikely to increase cancer riskTue, 9 Nov 2010, 22:35:05 UTC
- Menopausal hormone therapy may increase risk of ovarian cancerTue, 9 Nov 2010, 17:37:07 UTC
- Exercise may reduce risk of endometrial cancerTue, 9 Nov 2010, 17:37:06 UTC
- Soy isoflavones may modify risk of breast cancerMon, 8 Nov 2010, 23:33:11 UTC
- Could lung cancer in smokers vs. 'never-smokers' be different diseases?Mon, 8 Nov 2010, 23:33:10 UTC
- Smoking increased risk of death in women with breast cancerMon, 8 Nov 2010, 23:33:08 UTC
- Obesity not linked to breast cancer in Mexican-American womenMon, 8 Nov 2010, 23:33:07 UTC
- Chemoprevention biomarker for breast cancer identifiedMon, 8 Nov 2010, 18:32:58 UTC
- Gefitinib may have chemopreventive benefits in pancreatic cancerMon, 8 Nov 2010, 18:32:58 UTC
- Lasofoxifene reduces breast cancer risk in postmenopausal osteoporotic womenThu, 4 Nov 2010, 20:54:20 UTC
- Breast cancer survivors often rate post-treatment breast appearance only 'fair'Tue, 2 Nov 2010, 15:04:21 UTC
- Fox Chase researchers identify risk factors for the spread of breast cancer to lymph nodesTue, 2 Nov 2010, 14:04:13 UTC
- Breast density, no lobular involution increase breast cancer riskFri, 29 Oct 2010, 20:31:56 UTC
- Genetic variants may affect the risk of breast cancer in women with BRCA2 mutationsThu, 28 Oct 2010, 21:35:11 UTC
- Research rejects green tea for breast cancer preventionThu, 28 Oct 2010, 7:02:42 UTC
Other sources
- New risk factor for developing breast cancerfrom PhysorgWed, 10 Nov 2010, 15:30:52 UTC
- New risk factor for developing breast cancerfrom Science BlogWed, 10 Nov 2010, 15:30:27 UTC
- Chemoprevention biomarker for breast cancer identifiedfrom Science DailyWed, 10 Nov 2010, 14:31:27 UTC
- Cancer patients out of pocketfrom Science AlertWed, 10 Nov 2010, 12:30:34 UTC
- Long-term statin use is unlikely to increase cancer risk, study findsfrom Science DailyWed, 10 Nov 2010, 0:31:02 UTC
- Long-term statin use is unlikely to increase cancer risk: studyfrom PhysorgTue, 9 Nov 2010, 23:02:10 UTC
- Exercise Lowers Risk of Getting a Uterine Cancerfrom Live ScienceTue, 9 Nov 2010, 21:01:16 UTC
- Breast Cancer Prevention Drugs Get a Target to Aim Atfrom Live ScienceTue, 9 Nov 2010, 21:01:15 UTC
- Soy isoflavones may modify risk of breast cancerfrom Science DailyTue, 9 Nov 2010, 19:31:09 UTC
- Smoking increases risk of death in women with breast cancer, study findsfrom Science DailyTue, 9 Nov 2010, 19:31:03 UTC
- Menopausal hormone therapy may increase risk of ovarian cancerfrom PhysorgTue, 9 Nov 2010, 19:30:40 UTC
- Exercise may reduce risk of endometrial cancerfrom PhysorgTue, 9 Nov 2010, 19:00:42 UTC
- Soy Compounds May Cut Risk of Some Breast Cancersfrom Live ScienceTue, 9 Nov 2010, 16:50:38 UTC
- Soy isoflavones may modify risk of breast cancerfrom PhysorgMon, 8 Nov 2010, 23:50:20 UTC
- Could lung cancer in smokers vs. 'never-smokers' be different diseases?from PhysorgMon, 8 Nov 2010, 23:50:19 UTC
- Smoking increased risk of death in women with breast cancerfrom PhysorgMon, 8 Nov 2010, 23:50:17 UTC
- Obesity not linked to breast cancer in Mexican-American womenfrom PhysorgMon, 8 Nov 2010, 23:50:16 UTC
- Gefitinib may have chemopreventive benefits in pancreatic cancerfrom PhysorgMon, 8 Nov 2010, 19:00:30 UTC
- Chemoprevention biomarker for breast cancer identifiedfrom PhysorgMon, 8 Nov 2010, 18:30:52 UTC
- Anti-gout drug may decrease risk for colorectal adenoma progressionfrom PhysorgMon, 8 Nov 2010, 18:00:17 UTC
- Lasofoxifene reduces breast cancer risk in postmenopausal osteoporotic womenfrom Science DailySun, 7 Nov 2010, 5:24:52 UTC
- Lasofoxifene reduces breast cancer risk in postmenopausal osteoporotic womenfrom PhysorgThu, 4 Nov 2010, 21:50:11 UTC
- Breast cancer survivors often rate post-treatment breast appearance only 'fair'from Science DailyTue, 2 Nov 2010, 15:30:15 UTC
- Risk factors for the spread of breast cancer to lymph nodes identifiedfrom Science DailyTue, 2 Nov 2010, 15:30:12 UTC
- Breast cancer survivors often rate post-treatment breast appearance only 'fair'from PhysorgTue, 2 Nov 2010, 15:00:27 UTC
- Breast cancer survivors often rate post-treatment breast appearance only ‘fair’from Science BlogTue, 2 Nov 2010, 15:00:21 UTC
- Fox Chase researchers identify risk factors for the spread of breast cancer to lymph nodesfrom PhysorgTue, 2 Nov 2010, 14:30:49 UTC
- Fox Chase researchers identify risk factors for the spread of breast cancer to lymph nodesfrom Science BlogTue, 2 Nov 2010, 14:00:16 UTC
- Breast density, no lobular involution increase breast cancer risk, study findsfrom Science DailySun, 31 Oct 2010, 1:30:39 UTC
- Breast density, no lobular involution increase breast cancer riskfrom PhysorgFri, 29 Oct 2010, 22:00:20 UTC
- New breast cancer screening put to testfrom PhysorgFri, 29 Oct 2010, 12:30:46 UTC
- Green tea of no use in breast cancer prevention, large study findsfrom Science DailyFri, 29 Oct 2010, 4:30:45 UTC
- Genetic variants may affect the risk of breast cancer in women with BRCA2 mutationsfrom Science DailyThu, 28 Oct 2010, 23:30:22 UTC
- Genetic variants may affect the risk of breast cancer in women with BRCA2 mutationsfrom PhysorgThu, 28 Oct 2010, 22:00:46 UTC
- Not in the Bag: Green Tea Doubted as Breast Cancer Shieldfrom Live ScienceThu, 28 Oct 2010, 21:00:27 UTC
- Doubt Cast on Green Tea as Breast Cancer Shieldfrom Live ScienceThu, 28 Oct 2010, 17:30:46 UTC
- Research rejects green tea for breast cancer preventionfrom PhysorgThu, 28 Oct 2010, 7:00:28 UTC